Nature Biotechnology
banner
natbiotech.nature.com
Nature Biotechnology
@natbiotech.nature.com
Publishing the best of biotech science and business. Find us on Twitter, Facebook & Instagram. Part of @natureportfolio.nature.com‬.
The suitability of different AAV capsids for gene therapy is assessed in human livers go.nature.com/3PWpD4o
rdcu.be/eUK3m
AAV capsid prioritization in normal and steatotic human livers maintained by machine perfusion - Nature Biotechnology
The suitability of different AAV capsids for gene therapy is assessed in human livers.
go.nature.com
December 16, 2025 at 2:48 AM
Reposted by Nature Biotechnology
Predicting better lipids: In a cover-winning @natbiotech.nature.com paper, the Anderson & Langer Labs screened 1.6M lipids in silico to speed up successful designs for mRNA delivery to lungs. www.nature.com/articles/s41...
December 12, 2025 at 5:15 PM
Reposted by Nature Biotechnology
Our @natbiotech.nature.com editorial team picks our favorite research articles from 2025. We’ve also posted a Chinese version here 👉 mp.weixin.qq.com/s/fY10zwuljH...
December 9, 2025 at 7:36 AM
Our editors pick their favorite research articles from 2025 go.nature.com/4oCK84L
December 12, 2025 at 5:21 PM
The December issue is live nature.com/nbt/volumes/...

Hybrid quantum computing for drug design. Ghazi Vakili et al. present a hybrid quantum–classical generative model to design molecules to inhibit KRAS activity. Two candidates are synthesized and further characterized go.nature.com/3EitbLm
December 12, 2025 at 3:09 PM
The outlook for patients with certain forms of fibrosis has finally started to brighten, after a string of clinical trial setbacks over the past decade. In October @US_FDA approved @Boehringer's oral drug Jascayd (nerandomilast) for idiopathic pulmonary fibrosis www.nature.com/articles/s41...
FDA approves new mechanism to treat idiopathic pulmonary fibrosis, expanding limited arsenal - Nature Biotechnology
The first-in-class small molecule Jascayd targets a fibrotic signaling cascade, offering new hope in a stagnant therapeutic field, as several other programs near maturity.
www.nature.com
December 11, 2025 at 5:16 PM
Obituary: David Baltimore (1938–2025) go.nature.com/4959dRm
David Baltimore (1938–2025) - Nature Biotechnology
Nature Biotechnology - David Baltimore (1938–2025)
go.nature.com
December 10, 2025 at 5:01 PM
A scaffold-free bioprinting approach achieves physiological cell densities, and is used to print in vitro models of heart and liver structures, and neural circuits #NBThighlight www.cell.com/cell/fulltex...
Biomaterial-minimalistic photoactivated bioprinting of cell-dense tissues
We developed a bioprinting strategy that turns living cells into cell-only bioinks, enabling light-based 3D bioprinting of tissues at native, ultrahigh cell densities (up to ∼109 cells mL−1) to rapidl...
www.cell.com
December 9, 2025 at 2:46 PM
RNA sequestration in P-bodies stabilizes cell-fate transitions by repressing past identities — a process that can be harnessed to control cell fate #NBTNV go.nature.com/4iyZmGv
rdcu.be/eTR4A
Modulating RNA condensates to control cell fate - Nature Biotechnology
RNA sequestration in P-bodies stabilizes cell-fate transitions by repressing past identities — a process that can be harnessed to control cell fate.
go.nature.com
December 9, 2025 at 2:12 PM
2025: research in review go.nature.com/4oCK84L
December 8, 2025 at 7:47 PM
In vivo gene editing of human hematopoietic stem and progenitor cells using envelope-engineered virus-like particles - @uclpophealthsci.bsky.social go.nature.com/4a39S6X
In vivo gene editing of human hematopoietic stem and progenitor cells using envelope-engineered virus-like particles - Nature Biotechnology
Virus-like particles are engineered to edit human hematopoietic cells in vivo.
go.nature.com
December 8, 2025 at 6:53 PM
Reposted by Nature Biotechnology
By creating a network of early-career principal investigators, Gianvito Scaringi and his colleagues have enacted change and battled bureaucracy. You can read more about how a group of novice lab leaders are supporting each other: spklr.io/63329B5TIW

#AcademicSky
‘Anyone hired a student before?’ How a group of novice lab leaders are supporting each other
By creating a network of early-career principal investigators, my colleagues and I have enacted change and battled bureaucracy.
spklr.io
December 7, 2025 at 1:45 PM
Reposted by Nature Biotechnology
Harmful debris and inflammation in the brain caused by hemorrhagic stroke are treated by ultrasound therapy in a mouse model #NBTNV go.nature.com/4hWkUwE
rdcu.be/eSP1Q
Ultrasound mops up damage from hemorrhagic stroke - Nature Biotechnology
Harmful debris and inflammation in the brain caused by hemorrhagic stroke are treated by ultrasound therapy in a mouse model.
go.nature.com
December 6, 2025 at 3:26 PM
Obituary: Pedro Cuatrecasas (1936–2025) go.nature.com/4pHtmCC
Pedro Cuatrecasas (1936–2025) - Nature Biotechnology
Nature Biotechnology - Pedro Cuatrecasas (1936–2025)
go.nature.com
December 4, 2025 at 5:07 PM
A deep learning model trained on experimental data from high-throughput screening identifies structurally novel antimicrobial compounds #NBTNV go.nature.com/47fxSSv
rdcu.be/eSIvL
Deep learning speeds the search for new antibiotic scaffolds - Nature Biotechnology
A deep learning model trained on experimental data from high-throughput screening identifies structurally novel antimicrobial compounds.
go.nature.com
December 4, 2025 at 4:50 PM
A statistical framework quantifies single-cell batch variation and recovers meaningful biological signals go.nature.com/4hZnzW5
rdcu.be/eRy6o
Recovery of biological signals lost in single-cell batch integration with CellANOVA - Nature Biotechnology
A statistical framework quantifies single-cell batch variation and recovers meaningful biological signals.
go.nature.com
December 4, 2025 at 4:49 PM
Biotech news from around the world: Uganda, UK, Brazil, India nature.com/articles/s41...
rdcu.be/eSP9B
Biotech news from around the world - Nature Biotechnology
Nature Biotechnology - Biotech news from around the world
nature.com
December 3, 2025 at 11:52 PM
Standardized metrics for assessment and reproducibility of imaging-based spatial transcriptomics datasets - @jasmineplummer.bsky.social @lgmartelotto.bsky.social go.nature.com/4rBC1Z0
Standardized metrics for assessment and reproducibility of imaging-based spatial transcriptomics datasets - Nature Biotechnology
A multi-institute, multi-platform initiative generates standard metrics and best practices for spatial transcriptomics analysis.
go.nature.com
December 3, 2025 at 7:58 PM
Recent patents relating to mRNA vaccine compositions and methods of use go.nature.com/48dVmb4
rdcu.be/eSP7I
mRNA vaccines - Nature Biotechnology
Recent patents relating to mRNA vaccine compositions and methods of use.
go.nature.com
December 3, 2025 at 4:49 PM